全部分类
  • BMS 599626 dihydrochloride
BMS 599626 dihydrochloride的可视化放大

BMS 599626 dihydrochloride

EGFR and ErbB2 inhibitor,potent and selective

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

BMS 599626 dihydrochloride的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 5mg
    ¥1112.00
    890.00
    - +
  • 25mg
    ¥3387.00
    2710.00
    - +
  • 100mg
    ¥5925.00
    4740.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx11260
  • CAS: N/A
  • 别名:
  • 分子式: C27H27FN8O3.2HCl
  • 分子量: 603.48
  • 纯度: >98%
  • 溶解度: Soluble in DMSO > 10 mM
  • 储存: Store at -20°C
  • 库存: 现货

Background

BMS 599626 dihydrochloride is a potent and selective inhibitor of EGFR and ErbB2 with IC50 values of 22 and 32 nM, respectively [1].


The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation. Receptor tyrosine-protein kinase erbB-2 (ErbB2) is a human epidermal growth factor receptor and plays a critical role in breast cancer.


BMS 599626 dihydrochloride is a potent and selective EGFR and ErbB2 inhibitor. BMS-599626 inhibited HER4 with IC50 value of 190 nM. In Sal2, N87 and GEO tumor cells, BMS-599626 inhibited phosphorylation of HER1 and HER2 in a dose-dependent way and inhibited cell proliferation. In AU565 breast cancer cells, BMS-599626 (1μM) inhibited HER1/HER2 heterodimer formation [1]. In tumor cells that forming HER1/HER2 heterodimers, BMS-599626 inhibited heterodimerization [2].


In the L2987 human lung tumors xenograft models, BMS-599626 (60 mg/kg) inhibited and delayed tumor growth in a dose-dependent way [1].

参考文献:
[1].? Gavai AV, Fink BE, Fairfax DJ, et al. Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinases. J Med Chem, 2009, 52(21): 6527-6530.
[2].? Wong TW, Lee FY, Yu C, et al. Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling. Clin Cancer Res, 2006, 12(20 Pt 1): 6186-6193.

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算